Small but Mighty: Nanobodies in the Fight Against Infectious Diseases

Area of Science:

• Immunology
• Biotechnology
• Infectious Disease Research

Background:

• Infectious diseases are a major global health concern, necessitating effective treatments.
• Conventional antibody-based therapies face limitations in cost, accessibility, and stability.
• Nanobodies (Nbs) are emerging as a powerful alternative in therapeutic development.

Purpose of the Study:

• To review the potential of Nanobodies (Nbs) in treating infectious diseases.
• To discuss the mechanisms and intervention strategies of Nbs against viral and bacterial infections.

Main Methods:

• Literature review focusing on Nanobody applications in infectious disease treatment.
• Analysis of Nanobody characteristics, including affinity, specificity, stability, and production.

Main Results:

• Nanobodies offer advantages over conventional antibodies: high affinity, specificity, cost-effectiveness, accessibility, and stability.
• Nbs demonstrate significant potential for therapeutic intervention in both viral and bacterial infections.

Conclusions:

• Nanobodies represent a promising class of reagents for developing novel treatments against infectious diseases.
• Further research into Nanobody mechanisms and applications is warranted to combat global health threats.